Phreesia, Inc. $PHR Position Increased by Farther Finance Advisors LLC

Farther Finance Advisors LLC increased its stake in Phreesia, Inc. (NYSE:PHR) by 9,375.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,032 shares of the company’s stock after purchasing an additional 3,000 shares during the period. Farther Finance Advisors LLC’s holdings in Phreesia were worth $86,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the stock. Diversified Trust Co lifted its holdings in shares of Phreesia by 1.0% in the 2nd quarter. Diversified Trust Co now owns 45,042 shares of the company’s stock worth $1,282,000 after purchasing an additional 426 shares during the last quarter. Arcadia Investment Management Corp MI lifted its holdings in shares of Phreesia by 0.7% in the 1st quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company’s stock worth $2,371,000 after purchasing an additional 615 shares during the last quarter. QRG Capital Management Inc. lifted its holdings in shares of Phreesia by 8.0% in the 1st quarter. QRG Capital Management Inc. now owns 11,118 shares of the company’s stock worth $284,000 after purchasing an additional 827 shares during the last quarter. Hsbc Holdings PLC lifted its holdings in shares of Phreesia by 9.0% in the 1st quarter. Hsbc Holdings PLC now owns 14,241 shares of the company’s stock worth $356,000 after purchasing an additional 1,177 shares during the last quarter. Finally, Smartleaf Asset Management LLC lifted its holdings in shares of Phreesia by 53.0% in the 1st quarter. Smartleaf Asset Management LLC now owns 5,267 shares of the company’s stock worth $137,000 after purchasing an additional 1,825 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Price Performance

NYSE:PHR opened at $23.25 on Friday. The business’s 50-day moving average price is $26.91 and its 200 day moving average price is $26.27. The firm has a market cap of $1.39 billion, a P/E ratio of -55.35 and a beta of 0.68. The company has a quick ratio of 2.12, a current ratio of 2.12 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $32.76.

Phreesia (NYSE:PHR) last announced its earnings results on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.08. The company had revenue of $117.26 million for the quarter, compared to analyst estimates of $116.39 million. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.Phreesia’s revenue for the quarter was up 14.9% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.03) earnings per share. Phreesia has set its FY 2026 guidance at EPS. As a group, sell-side analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Insider Activity at Phreesia

In related news, General Counsel Allison C. Hoffman sold 2,059 shares of the company’s stock in a transaction on Wednesday, September 17th. The stock was sold at an average price of $23.50, for a total transaction of $48,386.50. Following the transaction, the general counsel directly owned 136,978 shares of the company’s stock, valued at approximately $3,218,983. The trade was a 1.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider David Linetsky sold 1,064 shares of the company’s stock in a transaction on Wednesday, September 17th. The shares were sold at an average price of $23.50, for a total value of $25,004.00. Following the transaction, the insider directly owned 173,888 shares in the company, valued at $4,086,368. The trade was a 0.61% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 94,812 shares of company stock valued at $2,782,535. Corporate insiders own 5.50% of the company’s stock.

Analysts Set New Price Targets

PHR has been the topic of several recent research reports. Truist Financial raised their price target on Phreesia from $35.00 to $36.00 and gave the stock a “buy” rating in a report on Friday, September 5th. Raymond James Financial set a $33.00 target price on Phreesia and gave the company an “outperform” rating in a research note on Friday, September 5th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Phreesia in a research note on Saturday, September 27th. Stephens reaffirmed an “overweight” rating and set a $32.00 target price on shares of Phreesia in a research note on Wednesday, September 3rd. Finally, Mizuho started coverage on Phreesia in a research note on Wednesday, August 27th. They set an “outperform” rating and a $36.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $34.08.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.